Revenue
2018
2019
2020
2021
2022
2023
2024
2025
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.00B | $11.02B | $9.87B | $8.93B | $7.57B | $6.21B | $4.16B | $3.05B | $2.49B | $1.70B | $1.03B | $580.4M | $1.21B | $1.53B | $1.41B | $143.4M | $101.9M | $175.5M |
| Research & development | $3.91B | $3.63B | $3.16B | $2.54B | $1.94B | $1.64B | $1.75B | $1.42B | $1.32B | $1.05B | $995.9M | $855.5M | $882.1M | $765.9M | $707.7M | $637.4M | $550.3M | $516.9M |
| Operating income | $4.17B | −$232.9M | $3.83B | $4.31B | $2.78B | $2.86B | $1.20B | $635.1M | $123.2M | $9.9M | −$466.9M | −$692.4M | −$610.0M | $46.7M | $113.8M | −$696.1M | −$614.0M | −$462.7M |
| EBITDAderived | $4.38B | −$25.7M | $4.01B | $4.46B | $2.91B | $2.97B | $1.30B | $707.6M | $184.6M | $71.3M | −$404.5M | −$629.2M | −$561.6M | $84.9M | $148.9M | −$665.6M | −$583.9M | −$430.5M |
| Net income | $3.95B | −$535.6M | $3.62B | $3.32B | $2.34B | $2.71B | $1.18B | $2.10B | $263.5M | −$112.1M | −$556.3M | −$738.6M | −$445.0M | −$107.0M | $29.6M | −$754.6M | −$642.2M | −$459.9M |
| Basic EPSper diluted share | $15.46 | -$2.08 | $14.05 | $12.97 | $9.09 | $10.44 | $4.58 | $8.24 | $1.06 | -$0.46 | -$2.31 | -$3.14 | -$1.98 | -$0.50 | $0.14 | -$3.77 | -$3.71 | -$3.27 |
| Diluted EPSper diluted share | $15.32 | -$2.08 | $13.89 | $12.82 | $9.01 | $10.29 | $4.51 | $8.09 | $1.04 | -$0.46 | -$2.31 | -$3.14 | -$1.98 | -$0.50 | $0.14 | -$3.77 | -$3.71 | -$3.27 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 26, 2026Form 4 · 10b5-1 | Bozic CarmenEVP and CMO | SellCommon Stock | 596 | $482.50 | $287.6K | 15.3K |
| Jun 18, 2026Form 4 · 10b5-1 | Bozic CarmenEVP and CMO | SellCommon Stock | 1.0K | $462.17 | $471.4K | 15.9K |
| Jun 15, 2026Form 4 · 10b5-1 | Bozic CarmenEVP and CMO | SellCommon Stock | 4.1K | $450.00 | $1.83M | 17.0K |
| Jun 5, 2026Form 4 · 10b5-1 | Bozic CarmenEVP and CMO | SellCommon Stock | 1.7K | $450.00 | $785.3K | 21.0K |
| Jun 1, 2026Form 4 · 10b5-1 | Liu JoyEVP and Chief Legal Officer | SellCommon Stock | 828 | $439.91 | $364.2K | 20.0K |